Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 21;13(7):500-512.
doi: 10.1093/jmcb/mjab024.

Diabetes pathogenesis and management: the endothelium comes of age

Kaitlin M Love  1 , Eugene J Barrett  1 , Steven K Malin  2   3   4   5 , Jane E B Reusch  6   7   8 , Judith G Regensteiner  6   7 , Zhenqi Liu  1
Affiliations

Diabetes pathogenesis and management: the endothelium comes of age

Kaitlin M Love et al. J Mol Cell Biol. .

Abstract

Endothelium, acting as a barrier, protects tissues against factors that provoke insulin resistance and type 2 diabetes and itself responds to the insult of insulin resistance inducers with altered function. Endothelial insulin resistance and vascular dysfunction occur early in the evolution of insulin resistance-related disease, can co-exist with and even contribute to the development of metabolic insulin resistance, and promote vascular complications in those affected. The impact of endothelial insulin resistance and vascular dysfunction varies depending on the blood vessel size and location, resulting in decreased arterial plasticity, increased atherosclerosis and vascular resistance, and decreased tissue perfusion. Women with insulin resistance and diabetes are disproportionately impacted by cardiovascular disease, likely related to differential sex-hormone endothelium effects. Thus, reducing endothelial insulin resistance and improving endothelial function in the conduit arteries may reduce atherosclerotic complications, in the resistance arteries lead to better blood pressure control, and in the microvasculature lead to less microvascular complications and more effective tissue perfusion. Multiple diabetes therapeutic modalities, including medications and exercise training, improve endothelial insulin action and vascular function. This action may delay the onset of type 2 diabetes and/or its complications, making the vascular endothelium an attractive therapeutic target for type 2 diabetes and potentially type 1 diabetes.

Keywords: diabetes; endothelium; insulin resistance; vascular function.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endothelial insulin signaling and the associated consequences in health and diabetes. ET-1, endothelin-1; ICAM-1, intercellular adhesion molecule 1; MEK, MAPK kinase.
Figure 2
Figure 2
Insulin resistance in endothelium and tissue: a two-stepped process.
Figure 3
Figure 3
Arterial functions and the impact of endothelial insulin resistance and dysfunction.
See this image and copyright information in PMC

References

    1. Adamska A., Araszkiewicz A., Pilacinski S., et al. (2019). Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes. Microvasc. Res. 121, 46–51. - PubMed
    1. Adlanmerini M., Solinhac R., Abot A., et al. (2014). Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc. Natl Acad. Sci. USA 111, E283–E290. - PMC - PubMed
    1. Aird W.C. (2007). Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100, 158–173. - PubMed
    1. Ayaori M., Iwakami N., Uto-Kondo H., et al. (2013). Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients. J. Am. Heart Assoc. 2, e003277. - PMC - PubMed
    1. Ban K., Noyan-Ashraf M.H., Hoefer J., et al. (2008). Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117, 2340–2350. - PubMed

Publication types

MeSH terms

Substances